Innovex (INVX) CEO sells 13,241 shares under Rule 10b5-1 plan sale

Q: At what price were Adam Anderson's Innovex (INVX) shares sold?

The 13,241 Innovex common shares were sold at a price of $25 per share , as shown in the transaction table.

Q: Was the Innovex (INVX) insider sale made under a Rule 10b5-1 plan?

Yes. A footnote explains the sale was made pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025 , which pre-arranges trades.

Q: What role does Adam Anderson hold at Innovex (INVX)?

Adam Anderson is identified as a director and Chief Executive Officer of Innovex International, Inc. in the filing.

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Innovex International, Inc. (INVX) Chief Executive Officer and director Adam Anderson reported selling 13,241 shares of common stock on January 14, 2026. The sale, coded as an open market sale, was executed at a price of $25 per share and was carried out under a Rule 10b5-1 trading plan adopted on March 14, 2025, which is designed to pre-arrange trades. Following this transaction, Anderson directly beneficially owns 498,822 shares of Innovex common stock.

Insider Trade Summary

Net Seller: 13,241 shares ($331,025)

Net Sell 1 txn

Insider Anderson Adam

Role Chief Executive Officer

Sold 13,241 shs ($331K)

Type	Security	Shares	Price	Value
Sale	Common Stock	13,241	$25.00	$331K

Holdings After Transaction: Common Stock — 498,822 shares (Direct)

Footnotes (1)

Sales pursuant to a Rule 10b5-1 plan adopted on March 14, 2025. All shares were sold at the price in column 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 01/15/2026 - 06:30 PM

FAQ

What insider transaction did Innovex (INVX) report for Adam Anderson?

Innovex International, Inc. reported that Chief Executive Officer and director Adam Anderson sold 13,241 shares of common stock on January 14, 2026.

At what price were Adam Anderson's Innovex (INVX) shares sold?

The 13,241 Innovex common shares were sold at a price of $25 per share, as shown in the transaction table.

How many Innovex (INVX) shares does Adam Anderson own after the sale?

After the reported transaction, Adam Anderson beneficially owns 498,822 shares of Innovex International, Inc. common stock in direct form.

Was the Innovex (INVX) insider sale made under a Rule 10b5-1 plan?

Yes. A footnote explains the sale was made pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025, which pre-arranges trades.

What role does Adam Anderson hold at Innovex (INVX)?

Adam Anderson is identified as a director and Chief Executive Officer of Innovex International, Inc. in the filing.

Did the Innovex (INVX) Form 4 report any derivative securities transactions?

The filing includes a section for derivative securities, but the provided table shows no derivative transactions reported for this Form 4.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Anderson Adam

(Last)

(First)

(Middle)

C/O INNOVEX INTERNATIONAL, INC.

19120 KENSWICK DRIVE

(Street)

HUMBLE

77338

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Innovex International, Inc. [ INVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/14/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	01/14/2026		S		13,241⁽¹⁾	D	$25⁽²⁾	498,822	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Sales pursuant to a Rule 10b5-1 plan adopted on March 14, 2025.

2. All shares were sold at the price in column 4.

	/s/ Matt Steinheider, Attorney-in-Fact for Adam Anderson	01/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR